• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Anticancer Res . The Role of SARS-CoV-2 Spike Protein in the Growth of Cervical Cancer Cells

tetano

Editor, Senior Moderator
Anticancer Res


. 2024 May;44(5):1807-1815.
doi: 10.21873/anticanres.16982. The Role of SARS-CoV-2 Spike Protein in the Growth of Cervical Cancer Cells

Conner M Willson[SUP] 1 [/SUP], Marco Lequio[SUP] 2 [/SUP], Ziwen Zhu[SUP] 2 [/SUP], Mark R Wakefield[SUP] 2 [/SUP], Qian Bai[SUP] 2 [/SUP], Emerson Fajardo[SUP] 2 [/SUP], Huaping Xiao[SUP] 2 [/SUP], Samuel Leung[SUP] 2 [/SUP], Yujiang Fang[SUP] 3 2 [/SUP]



Affiliations
Abstract

Background/aim: Recently developed vaccines for the SARS-CoV-2 virus utilize endogenous production of the virus' spike protein (SP), allowing the host to develop an immune response. As a result of the novelty of this virus and its vaccines, little is known overall about the potential effects of the SP on the pathogenesis of neoplasia, either from vaccination or from infection. This study was designed to investigate whether SARS-CoV-2 SP has any direct effect on SiHa cervical cancer cells.
Materials and methods: The effects of SARS-CoV-2 SP on cervical cancer cell proliferation and apoptosis were investigated by using clonogenic cell survival assay, quick cell proliferation assay, and caspase-3 activity kits in a widely-used cervical cancer cell line, SiHa. RT-PCR and immunohistochemistry were also performed to determine the potential molecular mechanisms.
Results: The growth and proliferation of SiHa cancer cells were inhibited by SARS-CoV-2 SP. SARS-CoV-2 SP also induced apoptosis in SiHa cancer cells. The anti-proliferative effect of SARS-CoV-2 SP on SiHa cancer cells was associated with the up-regulation of the anti-proliferative molecule p53. The pro-apoptotic effect of SARS-CoV-2 SP on SiHa cells was associated with the up-regulation of the pro-apoptotic molecule TRAIL.
Conclusion: SARS-CoV-2 SP inhibits the growth of cervical cancer via up-regulation of p53 and TRAIL. Further studies are needed to elaborate on the potential effects of the SARS-CoV-2 SP on other cancer cell lines and normal physiological cell lines for comparison.

Keywords: SARS-CoV-2; TRAIL; apoptosis; cervical cancer; p53; proliferation; spike protein.

 
Back
Top Bottom